Re.#1 - 12 people (6 of whom were in the control group that only got the placebo) seems way too small a sample to draw any conclusions, so I‘m not surprised to see that this „study“ was funded by the manufacturers of the treatment in question.
It's enough for an initial study to show it's worth looking into further, and it ties in with the link from yesterday about ATP being the issue with Long Covid.
no subject
no subject
no subject
no subject
The biology makes sense.
Yes that study is tiny, I agree.
no subject